Insider Trading & Ownership of Avicenna Life Sci Master Fund LP

Location
New York, NY
Summary
The estimated value of insider holdings of Avicenna Life Sci Master Fund LP is at least $1,815,385 dollars as of 12 Feb 2026. Avicenna Life Sci Master Fund LP is the Director, 10%+ Owner of LEXICON PHARMACEUTICALS, INC. and owns shares of LEXICON PHARMACEUTICALS, INC. (LXRX) stock worth about $1.82M.
Signature
AVICENNA LIFE SCI MASTER FUND LP, By: Avicenna Life Sci Master GP LLC, its GP By: /s/ Raymond Debbane, Name: Raymond Debbane Title: Chief Executive Officer
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Avicenna Life Sci Master Fund LP and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Avicenna Life Sci Master Fund LP has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $1,815,385.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: LEXICON PHARMACEUTICALS, INC. ($1,815,385).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Avicenna Life Sci Master Fund LP

Insider Transactions Reported by Avicenna Life Sci Master Fund LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .